Evidence map›Paper›PMID 26908800›Full record

ArticleClinical infectious diseases : an official publication of the Infectious Diseases Society of America2016

Evaluation of the Centers for Disease Control and Prevention Recommendations for Hepatitis C Virus Testing in an Urban Emergency Department.

Yu-Hsiang Hsieh, Richard E Rothman, Oliver B Laeyendecker, Gabor D Kelen, Ama Avornu, Eshan U Patel, Jim Kim, Risha Irvin, David L Thomas, Thomas C Quinn

2 registry-linked trialsOpen access · bronzeAbstract readEvaluation Study
In one paragraph

Article in Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 2 registered trials, which are not on this map. Cited by 43 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
43citing papers in PubMed, 1 pooled it
6.5field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03767231 nanot yet recruitingnot on this mapstarted 2026, after this paper: background citation

Emergency Department Patient's Perceptions and Acceptability Toward a Novel Point-of-Care Hepatitis C Virus Viral Load Testing

TypeinterventionalSponsorJohns Hopkins UniversityRan2026 to 2027Enrolled200ConditionsHepatitis CArmsXpert HCV Viral Load Finger-stick Point-of-Care test (Cepheid)
NCT04162938 narecruitingnot on this mapstarted 2022, after this paper: background citation

Use of a Patient-Centered Electronic App to Increase Emergency Department Patient's Knowledge on HCV Infection, Disease Progression, and Care to Improve the HCV Care Continuum

TypeinterventionalSponsorJohns Hopkins UniversityRan2022 to 2026Enrolled308ConditionsHepatitis CArmsPatient-Centered Electronic App
3 · Its place in the literature

Who cites it

43 citing papers in PubMed, 1 synthesis or guideline pooled it, 77 citations in OpenAlex.

  1. Guideline
  2. Article
  3. Article
  4. Article
  5. Discordant performance of mpox serological assays.Journal of virological methods · 2024
    Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Preferences of Persons With or at Risk for Hepatitis C for Long-Acting Treatments.Clinical infectious diseases : an official publication of the Infectious Diseases Society of America · 2022
    Article
  12. Article
  13. Article
  14. Article
  15. Article
  16. Article
  17. Strategies to identify hepatitis C virus infection in patients receiving anticancer therapy: a cross-sectional study.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

10 authors at 2 institutions in 1 country.

Yu-Hsiang HsiehDepartment of Emergency Medicine.
Richard E RothmanDepartment of Emergency Medicine Division of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore.
Oliver B LaeyendeckerDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Gabor D KelenDepartment of Emergency Medicine.
Ama AvornuDepartment of Emergency Medicine.
Eshan U PatelDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Jim KimDepartment of Emergency Medicine.
Risha IrvinDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore.
David L ThomasDivision of Infectious Diseases, Johns Hopkins University School of Medicine, Baltimore.
Thomas C QuinnDivision of Intramural Research, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.
Johns Hopkins Medicine · USNational Institutes of Health · US

Funding

International Studies of the Acquired Immune Deficiency Syndrome (AIDS)ZIAAI000361 · NIAID · NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES · PI REDD, ANDREW · 2009 to 2025
$15.8M
HIV HCV Coinfection Antiviral Therapy and FibrosisR37DA013806 · NIDA · JOHNS HOPKINS UNIVERSITY · PI THOMAS, DAVID L · 2010 to 2019
$7.0M
Cost-Effectiveness of ED HIV Testing Program Agent-Based Modeling ApproachK01AI100681 · NIAID · JOHNS HOPKINS UNIVERSITY · PI HSIEH, YU-HSIANG · 2012 to 2015
$532k
Intramural NIH HHSNIAID NIH HHS K01 AI100681NIAID NIH HHS K01AI100681NIDA NIH HHS R37 DA013806NIDA NIH HHS R37DA013806
6 · The paper itself

Abstract

backgroundThe Centers for Disease Control and Prevention (CDC) recommends 1-time hepatitis C virus (HCV) testing in the 1945-1965 birth cohort, in addition to targeted risk-based testing. Emergency departments (EDs) are key venues for HCV testing because of the population served and success in HIV screening. We determined the burden of undocumented HCV infection in our ED, providing guidance for implementation of ED-based HCV testing.

methodsAn 8-week seroprevalence study was conducted in an urban ED in 2013. All patients with excess blood collected for clinical purposes were included. Demographic and clinical information including documented HCV infection was obtained from electronic medical records. HCV antibody testing was performed on excess samples.

resultsOf 4713 patients, 652 (13.8%) were HCV antibody positive. Of these, 204 (31.3%) had undocumented HCV infection. Among patients with undocumented infections, 99 (48.5%) would have been diagnosed based on birth cohort testing, and an additional 54 (26.5%) would be identified by risk-based testing. If our ED adhered to the CDC guidelines, 51 (25.0%) patients with undocumented HCV would not have been tested. Given an estimated 7727 unique ED patients with HCV infection in a 1-year period, birth cohort plus risk-based testing would identify 1815 undocumented infections, and universal testing would identify additional 526 HCV-infected persons.

conclusionsBirth cohort-based testing would augment identification of undocumented HCV infections in this ED 2-fold, relative to risk-based testing only. However, our data demonstrate that one-quarter of infections would remain undiagnosed if current CDC birth cohort recommendations were employed, suggesting that in high-risk urban ED settings a practice of universal 1-time testing might be more effective.

Indexed as

Centers for Disease Control and Prevention, U.S.Emergency Service, HospitalAdolescentAdultAgedAged, 80 and overFemaleHepacivirusHepatitis CHepatitis C AntibodiesHospitals, UrbanHumansMaleMass ScreeningMiddle AgedPractice Guidelines as TopicHepatitis C AntibodiesCDC recommendationsemergency departmentHCVHCV testingundiagnosed infection

Identifiers

PMID26908800
PMCPMC4826455
OpenAlexW2324586478

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.